177 related articles for article (PubMed ID: 10386248)
21. Strategies to improve plasma half life time of peptide and protein drugs.
Werle M; Bernkop-Schnürch A
Amino Acids; 2006 Jun; 30(4):351-67. PubMed ID: 16622600
[TBL] [Abstract][Full Text] [Related]
22. Uptake and fate of absorbed amino acids and peptides in the mammalian intestine.
Alpers DH
Fed Proc; 1986 Jul; 45(8):2261-7. PubMed ID: 3522278
[TBL] [Abstract][Full Text] [Related]
23. Intrarenal dopamine inhibits progression of diabetic nephropathy.
Zhang MZ; Yao B; Yang S; Yang H; Wang S; Fan X; Yin H; Fogo AB; Moeckel GW; Harris RC
Diabetes; 2012 Oct; 61(10):2575-84. PubMed ID: 22688335
[TBL] [Abstract][Full Text] [Related]
24. The Prescriber's Guide to the MAOI Diet-Thinking Through Tyramine Troubles.
Van den Eynde V; Gillman PK; Blackwell BB
Psychopharmacol Bull; 2022 May; 52(2):73-116. PubMed ID: 35721816
[TBL] [Abstract][Full Text] [Related]
25. Lipid Rafts and Dopamine Receptor Signaling.
Martinez VJ; Asico LD; Jose PA; Tiu AC
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255376
[TBL] [Abstract][Full Text] [Related]
26. Renal Dopamine Oxidation and Inflammation in High Salt Fed Rats.
Banday AA; Lokhandwala MF
J Am Heart Assoc; 2020 Jan; 9(1):e014977. PubMed ID: 31880979
[TBL] [Abstract][Full Text] [Related]
27. Influence of intraventricular application of baclofen on arterial blood pressure and neurotransmitter concentrations in the hypothalamic paraventricular nucleus of rats.
Czell D; Efe T; Preuss M; Schofer MD; Becker R
Neurochem Res; 2012 Feb; 37(2):381-6. PubMed ID: 21984200
[TBL] [Abstract][Full Text] [Related]
28. The neuropharmacology of (-)-stepholidine and its potential applications.
Yang K; Jin G; Wu J
Curr Neuropharmacol; 2007 Dec; 5(4):289-94. PubMed ID: 19305745
[TBL] [Abstract][Full Text] [Related]
29. [Dopamine receptor subtypes].
Janković SM; Milovanović D; Mitrović M; Dukić-Dejanović S
Med Pregl; 1996; 49(7-8):281-5. PubMed ID: 8926944
[TBL] [Abstract][Full Text] [Related]
30. Role of dopamine in the pathogenesis of hypertension.
Jose PA; Eisner GM; Felder RA
Clin Exp Pharmacol Physiol Suppl; 1999 Apr; 26():S10-3. PubMed ID: 10386248
[TBL] [Abstract][Full Text] [Related]
31. The peripheral dopaminergic system: morphological analysis, functional and clinical applications.
Amenta F; Ricci A; Tayebati SK; Zaccheo D
Ital J Anat Embryol; 2002; 107(3):145-67. PubMed ID: 12437142
[TBL] [Abstract][Full Text] [Related]
32. The dopaminergic system in hypertension.
Zeng C; Zhang M; Asico LD; Eisner GM; Jose PA
Clin Sci (Lond); 2007 Jun; 112(12):583-97. PubMed ID: 17492945
[TBL] [Abstract][Full Text] [Related]
33. D1 dopamine receptor signalling defect in spontaneous hypertension.
Felder RA; Eisner GM; Jose PA
Acta Physiol Scand; 2000 Jan; 168(1):245-50. PubMed ID: 10691808
[TBL] [Abstract][Full Text] [Related]
34. Dopamine receptors in hypertension.
Bek MJ; Eisner GM; Felder RA; Jose PA
Mt Sinai J Med; 2001 Nov; 68(6):362-9. PubMed ID: 11687863
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
